|
End-of-day quote
Korea S.E.
04/11/2026
|
5-day change | 1st Jan Change | ||
| 6,670.00 KRW | -1.33% |
|
-4.99% | -52.25% |
Company Valuation: Samik Pharmaceutical Company LTD.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 |
|---|---|
| Market Cap 1 | 128,125 |
| Change | - |
| Enterprise Value (EV) 1 | 99,073 |
| Change | - |
| P/E | -140x |
| PBR | 1.86x |
| PEG | 1x |
| Capitalization / Revenue | 2.13x |
| EV / Revenue | 1.65x |
| EV / EBITDA | 21.3x |
| EV / EBIT | 30.3x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | 40 |
| Rate of return | 0.29% |
| EPS 2 | -99.5 |
| Distribution rate | -40.2% |
| Net sales 1 | 60,020 |
| EBITDA 1 | 4,649 |
| EBIT 1 | 3,273 |
| Net income 1 | -754.9 |
| Net Debt 1 | -29,051 |
| Reference price 2 | 13,970.00 |
| Nbr of stocks (in thousands) | 9,171 |
| Announcement Date | 3/20/26 A |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 50.62M | |
| 41.24x | 13.94x | 30.97x | 0.48% | 1,255B | |
| 38.96x | 6.55x | 18.42x | 2.01% | 641B | |
| 36.79x | 8.37x | 17.26x | 2.42% | 505B | |
| 21.08x | 5.12x | 12.75x | 2.56% | 381B | |
| 95.75x | 5.88x | 25.02x | 2.35% | 357B | |
| 22.88x | 5.88x | 14.19x | 2.73% | 303B | |
| 24.26x | 4.85x | 13.68x | 1.8% | 286B | |
| 29.25x | 7.46x | 13.36x | 2.19% | 249B | |
| -40.09x | 7.32x | 45.96x | 1.97% | 208B | |
| Average | 30.01x | 7.26x | 21.29x | 2.06% | 418.53B | |
| Weighted average by Cap. | 35.93x | 8.73x | 22.53x | 1.73% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A014950 Stock
- Valuation Samik Pharmaceutical Company LTD.
Select your edition
All financial news and data tailored to specific country editions
